Hip Replacement Market

The global Hip Replacement Market is valued at USD 7.84 Billion in 2024 and is projected to reach a value of USD 12.73 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 4.5% between 2025 and 2035.

Osteoarthritis is a degenerative condition where the flexible tissues in the joints deteriorate, leading to severe joint pain. Sedentary lifestyles and the aging population are major causes of this disease. The number of senior people living in many countries, particularly in Europe and other developed countries like the U.S., is increasing. Increased diagnosis and treatment rates, along with heightened awareness of available treatment options particularly in emerging markets are driving a rise in the number of patients with osteoarthritis opting for Hip Replacement surgeries. Governments worldwide have introduced various reimbursement schemes for joint replacement surgeries to ensure affordable and high-quality care for all citizens.

Key Highlights

• In 2024, based on the Procedure, the Total Hip Replacement category accounted for significant market share of 73.5%
• Based on the Material, the Metal-on-Polyethylene category accounted for significant market share in 2024
• By End User, Hospitals segment dominated the market in 2024 with significant market share
• North America dominated the market with 35.2% market share in 2024
• Asia Pacific region is anticipated to grow at the highest CAGR during the forecast period

Procedure Overview

​The Procedure segment is divided into Total Hip Replacement, Material, End User. The Total Hip Replacement segment held the dominant share in 2024, accounting for significant market share of 73.5%.

THR procedures are widely preferred because they completely replace damaged hip joints with artificial components, ensuring better mobility and pain relief compared to partial replacements or other alternatives. The segments growth is further fueled by advancements in surgical techniques, including the use of robotic-assisted systems, which enhance precision and outcomes. According to an article in Rheumatology Advisor, projections indicate a sharp rise in total hip arthroplasty (THA) procedures: from 498,000 replacements in 2020, to 652,000 in 2025 (a 75% increase), 850,000 in 2030 (a 129% increase), and 1,429,000 by 2040 (a 284% increase). This growth, combined with the accelerating adoption of robotic technologies for THA, is expected to propel the segments expansion during the forecast period.

The partial replacement segment is also witnessing growth, driven by rising demand for minimally invasive procedures, a growing prevalence of hip osteoarthritis, and frequent new product launches. Additionally, the revision and hip resurfacing segment benefits from increasing cases requiring secondary procedures due to wear of implants and a shift in preference toward resurfacing techniques.

Material Overview

​The Material segment is divided into Metal-on-Metal, Metal-on-Polyethylene, Ceramic-on-Polyethylene, Ceramic-on-Metal, Ceramic-on-Ceramic. The Metal-on-Polyethylene segment held the dominant share in 2024, accounting for significant market share.

The Metal-on-Polyethylene material combination, which involves a metal femoral head paired with a polyethylene acetabular component, is highly favored due to its proven durability, wear resistance, and affordability. The widespread use of Metal-on-Polyethylene implants is attributed to their balance of performance and cost-effectiveness. The metal components, often made from cobalt-chromium or titanium alloys, offer strength and stability, while the polyethylene provides a smooth surface for joint movement, reducing friction and wear over time.

End User Overview

​The End User segment is divided into Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers. The Hospitals segment held the dominant share in 2024, accounting for significant market share.

Patients' preference for hospital-based treatments is increased by the broad use of innovative Hip Replacement devices that deliver superior results. The need for Hip Replacement devices in hospitals is driven by the increase in hospital admissions for hip-related conditions as well as the availability of qualified medical personnel. Moreover, hospitals offer extensive post-surgery care, including continuous monitoring, tailored workout regimens for strength restoration, close patient collaboration, and physical therapy services. Hospital preference is strengthened by this mix of expert care and well-equipped emergency orthopedic surgery departments, which increases sector income even more.

Regional Overview

In 2024, the North America captured 35.2% of the revenue share

North America Hip Replacement market is driven by the rise in hip arthroplasty procedures and growing strategic collaborations among major industry players. For instance, in September 2020, Conformis secured FDA clearance for the Cordera Hip System, likely boosting demand for arthroplasty implants in the U.S.

In Europe, the Hip Replacement market is projected to grow significantly due to favorable healthcare reimbursement policies, increased demand for customized implants, and a rising number of surgeries. Premier Healthcare reports that German surgeons perform approximately 200,000 Hip Replacement procedures annually.

The Asia Pacific market is expanding at fastest growth during the forecast period driven by increasing healthcare investments, a growing aging population, rising prevalence of orthopedic conditions, manufacturers expanding their presence through strategic partnerships, and the introduction of innovative products tailored to regional needs.

Latin America and the Middle East & Africa are expected to witness moderate growth during the forecast period driven by higher prevalence of hip osteoarthritis and increasing awareness about Hip Replacement procedures contribute to this trend.

Based on the provided market data, Vantage Market Research offers customizations in the reports to meet the specific needs of clients.

Key Trends

• Minimally invasive surgery: Growing adoption due to benefits like faster recovery times and reduced complications
• Patient-specific implants: Increased use of custom solutions, driven by 3D printing and advanced imaging technologies
• Durable materials: Shift towards ceramic and highly cross-linked polyethylene for improved implant longevity and reduced wear
• Robotic-assisted surgery: Rising use of robotic technology for enhanced surgical precision and improved outcomes
• Value-based healthcare: Emphasis on improving clinical outcomes and cost-effectiveness, fostering innovation in implant designs and surgical practices

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Dynamics

Rising Prevalence of Osteoarthritis to Propel Hip Implant Demand

Osteoarthritis, a progressive condition characterized by the deterioration of soft tissue in bone joints, increasingly affects older adults. As the disease advances, it leads to severe joint pain and damage, particularly in areas such as the hips and knees. =According to the World Health Organization (WHO), approximately 70% of individuals aged 55 and above globally suffer from osteoarthritis, highlighting its prevalence in the aging population. The growing geriatric demographic has significantly contributed to the rising incidence of hip osteoarthritis, driving demand for hip implants. Key players launched innovative products. For instance, in August 2023, Smith+Nephew introduced the OR3O Dual Mobility System in India for primary and revision hip arthroplasty. Thus, the increasing prevalence of hip osteoarthritis, coupled with a growing elderly population and a focus on innovative product development, is accelerating market growth.

Surge in Customized Hip Prostheses Adoption to Boost Market Growth

The hip implant market is expanding due to rising demand for personalized prostheses tailored to individual patient anatomies. Manufacturers are using 3D printing technology to create patient-specific implants since implant sizes differ depending on individual patient demands.The need for specialized solutions has grown dramatically since orthopaedic implants are now made using 3D printing. The development of sophisticated implants to improve surgical results is being prioritized by industry participants, which is propelling the hip implant markets expansion.

Legal Challenges and Product Recalls to Restrict Market Expansion

While Hip Replacement surgeries are becoming more common, complications linked to implant use remain a significant challenge for market growth. Issues such as allergic reactions, metal toxicity, and infections have led to numerous lawsuits and recalls. For instance, Zimmer Biomet and Stryker have faced multiple lawsuits due to malfunctioning devices. As of March 2023, there were 344 ongoing lawsuits against Stryker for replacement devices. Additionally, product recalls have hindered market trust. The U.S. FDA reported in March 2021 that Stryker issued an urgent recall of its Triathlon Total Knee System, while Zimmer Biomet recorded the highest recall rates, followed by Johnson & Johnson and Smith+Nephew.

Competitive Landscape

The Hip Replacement market is characterized by the presence of several key players, including major global medical device companies and specialized orthopedic firms. These companies, such as Stryker Corporation, Zimmer Biomet, Johnson & Johnson, and Smith & Nephew, dominate the market by offering a wide range of innovative products, from traditional metal-on-metal implants to advanced ceramic and polyethylene alternatives. The market is also influenced by factors like technological advancements in surgical techniques, the increasing demand for minimally invasive procedures, and the growing prevalence of hip-related conditions due to aging populations.

The key players in the global Hip Replacement market include - Conformis Inc among others.

Recent Market Developments

Zimmer Biomet Gains FDA Approval for Rosa Shoulder System

• In February 2024, Zimmer Biomet Holdings, Inc., a leading global medical technology company, announced that it has received FDA 510(k) clearance for the ROSA® Shoulder System, the first robotic platform designed specifically for shoulder replacement surgeries. This marks the fourth addition to Zimmer Biomet’s ROSA® Robotics portfolio, which also includes systems for total knee (ROSA® Knee) and total hip (ROSA® Hip) replacement procedures

Stryker Launches Ortho Q Guidance System for Hip and Knee Procedures

• In 2023, Stryker introduced its Ortho Q Guidance system, designed to provide advanced planning and guidance for hip and knee surgeries, with seamless control from within the sterile field. The system integrates cutting-edge optical tracking through a newly designed camera and the advanced algorithms of the Ortho Guidance software

Evonis Corporation Introduces Augmented Reality System for Hip Replacement

• In 2022, Enovis, a medical technology company focused on innovation, has launched ARVIS® (Augmented Reality Visualization and Information System) commercially, following its successful use in over 200 cases across the U.S. This FDA-cleared, proprietary augmented reality (AR) system offers real-time, hands-free precision guidance, specifically designed to assist orthopedic surgeons during hip and knee surgeries

Exactech, Inc. Unveils Logical Cup System and Spartan Stem for Hip Arthroplasty

• Exactech, a leading innovator in implants, surgical tools, and smart technologies for joint replacement procedures, announced the completion of the initial surgeries using the Spartan™ Stem and Logical™ Cup System for total Hip Replacement

The global Hip Replacement market can be categorized as Procedure, Material, End User and Region.